Please Donate ICVI’s 20th birthday
20 Year Appeal

Changing Lives Through Research


Professor Angus Dalgeish’s research team at St George’s University of London, funded by the charity ICVI, has been forced by lockdown to work away from their laboratory. The majority of our laboratory-based team are managing to work productively from home, holding their weekly laboratory meetings remotely and concentrating on writing papers and analysing data collected before lockdown. They are hoping to get back into the offices and labs at St George's in June. The team, led by Dr Mark Bodman Smith, have also been putting their minds to how their years of research into immunotherapy as a treatment for cancer could inform the current search for a vaccine for COVID-19. If you would like more information on this please email [email protected]

Dr Alberto Fusi is continuing to support patients on current trials (we are unable to recruit new trial participants at the moment), supported by a data manager and research nurse. He is also working on the front line at St George’s Hospital.

Professor Dalgleish has been working towards designing a trial for a vaccine for COVID-19 and has had a paper published in the Cambridge University Press regarding this. A layman's summary of this paper is available under the 'News' section of this website.

An article by Professor Dalgleish was published in the Daily Telegraph at the end of March which provides more information. Please visit the 'Our Research/Research' pages of our website for more information regarding this, as well as to read the article in full.

Professor Dalgleish recently made a film about the use of BCG as a treatment for cancer, and you can see the film below.

Our charity office is closed at the moment and we are working from home. For any urgent enquiries, including press enquiries please email [email protected] with details and a phone number and someone will respond to your email.

Founded in 2000, the Institute for Cancer Vaccines and Immunotherapy is a unique charity which exclusively funds research into cancer immunotherapy and vaccines.

Our Principal, Professor Angus Dalgleish, Professor of Oncology at St. George’s University of London, has been a pioneer in this type of research for many years. ICVI raises funds to support his research team. All research is directly informed by Professor Dalgleish’s patients. This unique dynamic enables the improvement of patients’ survival rates and their quality of life for a wide range of cancers. We believe this is the future of cancer research.

Read More